Braintech, Inc., a provider of software products that offer robust, scalable and transferable Vision Guided Robotic (VGR) solutions used for industrial and government and defense service applications, recently announced that the company’s wholly owned subsidiary, Braintech Government & Defense, Inc., received a subcontract from BAE Systems on a U.S. government and defense contract. Braintech is currently developing automated assembly solutions based on its industry-leading VGR technology in Phase II of the Automated Weapons Assembly project for the Office of Naval Research.

Adam Marsh, BAE Systems’ program manager, commented, “With its unique vision guidance software technology and dedicated technical team, Braintech is developing a critical system component that was key to proving to the customer that weapon assembly could be automated. Mr. Marsh concluded, “This will reduce the number of sailors required, reduce the risk of injuries and provide a reliable, repeatable process for the Navy. BAE Systems is very pleased

...

SOUTHBOROUGH, Mass. - October 15 2009 - Protonex Technology Corporation (LSE: AIM: PTX and PTXU), a leading provider of advanced fuel cell power systems, today announced that the Naval Research Laboratory (NRL), through a program sponsored by the Office of Naval Research (ONR), has documented a flight endurance record on their small, unmanned aerial vehicle (UAV), the Ion Tiger, utilizing a highly advanced fuel cell system from Protonex.

Raytheon Company (RTN) continues to be a solid Growth and Income pick with strong fundamentals, such as an industry-leading dividend yield of 3%. Raytheon's return on equity (ROE) of 18% tops the industry average of 15%. The company's net profit margin of 7.5% compares to an industry average of 6%.

Company Description

Raytheon Company is the one of the largest aerospace and defense companies in the U.S., with a well-diversified line of military products, including missiles, radars, sensors, surveillance and reconnaissance equipment, communication and information systems, naval systems, air traffic control systems, and technical services.

A Recent Contract

The company was recently awarded a $7 million follow-on contract from the Office of Naval Research to improve the semiconductors used by U.S. military agencies.

Stellar Fundamentals

Raytheon continues to be a solid Growth and Income pick with strong fundamentals, such as an industry-leading dividend yield of 3%. Raytheon's return on equity (ROE)

...

Nephros, Inc.

(OTC: NEPH)

A reader of StocksHaven Investments by the name of Michael Sklar has contributed the following article regarding Nephros, Inc. The article outlines one of the most undervalued BioPharma companies around, at only $1.08 PPS with three pending FDA decisions. If you are an avid investor of pre-PDUFA companies, StocksHaven Investments highly suggests you conduct some due diligence on this company, as its potential value greatly outweighs the risks involved. About: Nephros, Inc. (Nephros) is engaged primarily in the development of hemodiafiltration (HDF), products and technologies for treating patients with end stage renal disease (ESRD). The Company has three products in various stages of development in the HDF modality to deliver therapy to ESRD patients: OLpur MDHDF filter series (which it sells in various countries in Europe and consists of its MD190 and MD220 diafilters);

...